Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Douglas B. McGill"'
Autor:
Keith D. Lindor, Johnson L. Thistle, Jessica Henry, Terry M. Therneau, Darius Sorbi, Douglas B. McGill
Publikováno v:
The American Journal of Gastroenterology. 95:3206-3210
The role of liver biopsy in the management of patients with nonspecific chronic liver enzyme abnormalities is not well established. The aim of this study is to determine whether liver histology changes the clinical impression formed before liver biop
Autor:
Keith D. Lindor, Jeffrey S. Crippin, Jacqueline M. Laurin, Douglas B. McGill, Gregory J. Gores, Jurgen Ludwig, Jorge Rakela, Andrea A. Gossard
Publikováno v:
Hepatology. 23:1464-1467
Non-alcohol-induced steatohepatitis (NASH) is characterized by elevated serum aminotransferase activities with hepatic steatosis, inflammation, and occasionally fibrosis that may progress to cirrhosis. No established treatment exists for this potenti
Autor:
Alan R. Zinsmeister, Keith D. Lindor, Douglas B. McGill, Jurgen Ludwig, Kenneth P. Batts, Carl C. Reading, J Rodes, John B. Gross, Roberta A. Jorgensen, Jorge Rakela, E M James, J M Bordas, C Bru, J W Charboneau
Publikováno v:
Hepatology. 23:1079-1083
The risk of complications from percutaneous liver biopsy is low, but discomfort is common and complications require hospitalization in approximately 4% of patients. The optimal method of performing these biopsies is unknown. The goal of our study was
Autor:
Mark V. Larson, Douglas B. McGill
Publikováno v:
Current Opinion in Gastroenterology. 10:27-33
Publikováno v:
Gastroenterology. 105:1900-1908
MARK E. STARK,* DEIRDRE A. HERRINGTON,* GEORGE V. HILLYER,§ and DOUGLAS B. McGILLii *Division of Gastroenterology, Mayo Clinic Jacksonville, Jacksonville, Florida; *Division of Infectious Diseases, Bowman Gray School of Medicine, Wake Forest Univers
Autor:
Douglas B. McGill
Publikováno v:
Current Opinion in Gastroenterology. 8:25-30
Publikováno v:
Archives of Internal Medicine. 150:1041-1045
• To assess the contribution of fecal blood testing to cancer detection in a clinical practice setting, we studied records from 160 patients with both a new tissue diagnosis of colorectal adenocarcinoma and a preceding stool blood test (HemoQuant,
Publikováno v:
Mayo Clinic Proceedings. 65:51-55
Severe hepatic venous outflow obstruction and its manifestations often are recorded under the label "Budd-Chiari syndrome." Unfortunately, this label is ambiguous; it does not clearly identify the site of the lesion (hepatic veins versus inferior ven
Publikováno v:
Mayo Clinic proceedings. 78(6)
Objective To determine whether isoform separation of carbohydrate-deficient transferrin (CDT) is of value in the diagnosis of alcoholic liver disease (ALD) and is specific to ALD when compared with other liver diseases. Patients and Methods During 19